News
-
-
COMMUNIQUÉ DE PRESSE
Biophytis is deploying its partnership strategy in obesity
Biophytis announces the implementation of a dedicated partnership strategy in obesity, aiming to collaborate with global pharmaceutical companies for drug development and commercialization. CEO Stanislas Veillet emphasizes the importance of addressing the obesity medical challenge through partnerships -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Kingstone Announces Certain Preliminary First Quarter 2024 Results and Schedules Conference Call
Kingstone Companies, Inc. announces preliminary financial results for Q1 2024, highlighting profitable performance and material reduction in non-core policies-in-force. The company will hold a conference call on May 14, 2024 -
COMMUNIQUÉ DE PRESSE
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
Jaguar's plant-based drug crofelemer granted Orphan Drug Designation for MVID and SBS, with proof-of-concept studies planned for 2024. Napo sponsors Elite Ped-GI Congress panel discussion on rare digestive disorders -
